HMG-CoA Reductase Inhibitors in Chronic Heart Failure
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 66 (2) , 145-154
- https://doi.org/10.2165/00003495-200666020-00002
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- HMG-CoA Reductase Inhibitors Inhibit Endothelial Exocytosis and Decrease Myocardial Infarct SizeCirculation Research, 2005
- Cardiac effects of statins—advancements and open questionsCardiovascular Research, 2005
- Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failureThe American Journal of Cardiology, 2004
- Preservation of NO production by statins in the treatment of heart failureCardiovascular Research, 2003
- Rapid Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition on Coronary Endothelial FunctionCirculation Research, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Regulation of the mevalonate pathwayNature, 1990